Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
dc.contributor.author | Uretsky, Madeline | |
dc.contributor.author | Gibbons, Laura E. | |
dc.contributor.author | Mukherjee, Shubhabrata | |
dc.contributor.author | Trittschuh, Emily H. | |
dc.contributor.author | Fardo, David W. | |
dc.contributor.author | Boyle, Patricia A. | |
dc.contributor.author | Keene, C. Dirk | |
dc.contributor.author | Saykin, Andrew J. | |
dc.contributor.author | Crane, Paul K. | |
dc.contributor.author | Schneider, Julie A. | |
dc.contributor.author | Mez, Jesse | |
dc.contributor.department | Radiology and Imaging Sciences, School of Medicine | en_US |
dc.date.accessioned | 2023-03-20T19:05:41Z | |
dc.date.available | 2023-03-20T19:05:41Z | |
dc.date.issued | 2021-09-27 | |
dc.description.abstract | Introduction: Alzheimer's disease (AD) neuropathological subtypes (limbic predominant [lpAD], hippocampal sparing [HpSpAD], and typical [tAD]), defined by relative neurofibrillary tangle (NFT) burden in limbic and cortical regions, have not been studied in prospectively characterized epidemiological cohorts with robust cognitive assessments. Methods: Two hundred ninety-two participants with neuropathologically confirmed AD from the Religious Orders Study and Memory and Aging Project were categorized by neuropathological subtype based on previously specified diagnostic criteria using quantitative regional NFT counts. Rates of cognitive decline were compared across subtypes using linear mixed-effects models that included subtype, time, and a subtype-time interaction as predictors and four cognitive domain factor scores (memory, executive function, language, visuospatial) and a global score as outcomes. To assess if memory was relatively preserved in HpSpAD, non-memory factor scores were included as covariates in the mixed-effects model with memory as the outcome. Results: There were 57 (20%) with lpAD, 22 (8%) with HpSpAD and 213 (73%) with tAD. LpAD died significantly later than the participants with tAD (2.4 years, P = .01) and with HpSpAD (3.8 years, P = .03). Compared to tAD, HpSpAD, but not lpAD, performed significantly worse in all cognitive domains at the time of initial impairment and declined significantly faster in memory, language, and globally. HpSpAD did not have relatively preserved memory performance at any time point. Conclusion: The relative frequencies of AD neuropathological subtypes in an epidemiological sample were consistent with a previous report in a convenience sample. People with HpSpAD decline rapidly, but may not have a memory-sparing clinical syndrome. Cohort-specific differences in regional tau burden and comorbid neuropathology may explain the lack of clinicopathological correlation. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Uretsky M, Gibbons LE, Mukherjee S, et al. Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes. Alzheimers Dement (N Y). 2021;7(1):e12201. Published 2021 Sep 27. doi:10.1002/trc2.12201 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/31977 | |
dc.language.iso | en_US | en_US |
dc.publisher | Alzheimer’s Association | en_US |
dc.relation.isversionof | 10.1002/trc2.12201 | en_US |
dc.relation.journal | Alzheimer's & Dementia: Translational Research & Clinical Interventions | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.source | PMC | en_US |
dc.subject | Alzheimer's disease | en_US |
dc.subject | Cognitive decline | en_US |
dc.subject | Cognitive trajectories | en_US |
dc.subject | Executive function | en_US |
dc.subject | Hippocampal sparing | en_US |
dc.subject | Language | en_US |
dc.subject | Limbic predominant | en_US |
dc.subject | Memory | en_US |
dc.subject | Memory and Aging Project | en_US |
dc.subject | Neuropathological subtypes | en_US |
dc.subject | Religious Orders Study | en_US |
dc.subject | Visuospatial function | en_US |
dc.title | Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes | en_US |
dc.type | Article | en_US |